Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2013 4
2014 4
2015 3
2016 8
2017 5
2018 1
2019 5
2020 3
2021 7
2022 9
2023 6
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Bacterial endotoxins and exotoxins in intensive care medicine.
Sheehan JR, Sadlier C, O'Brien B. Sheehan JR, et al. Among authors: sadlier c. BJA Educ. 2022 Jun;22(6):224-230. doi: 10.1016/j.bjae.2022.01.003. Epub 2022 Mar 12. BJA Educ. 2022. PMID: 35614909 Free PMC article. Review. No abstract available.
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.
Byrne J, Gu L, Garcia-Leon A, Gaillard CM, Saini G, Alalwan D, Tomás-Cortázar J, Kenny G, Donohue S, Reynolds B, O'Gorman T, Landay A, Doran P, Stemler J, Koehler P, Cox RJ, Olesen OF, Lelievre JD, O'Broin C, Savinelli S, Feeney ER, O'Halloran JA, Cotter A, Horgan M, Kelly C, Sadlier C, de Barra E, Cornely OA, Gautier V, Mallon PW. Byrne J, et al. Among authors: sadlier c. Front Immunol. 2024 Sep 17;15:1445653. doi: 10.3389/fimmu.2024.1445653. eCollection 2024. Front Immunol. 2024. PMID: 39355249 Free PMC article.
Associations between type III interferons, obesity and clinical severity of COVID-19.
Alalwan D, Leon AAG, Saini G, Gaillard C, Negi R, Heckmann C, Kenny G, Feeney E, Cotter AG, Kelly C, Carr M, de Barra E, Yousif O, Horgan M, Sadlier C, Landay A, Gonzalez G, Mallon PWG. Alalwan D, et al. Among authors: sadlier c. Front Immunol. 2025 Apr 22;16:1516756. doi: 10.3389/fimmu.2025.1516756. eCollection 2025. Front Immunol. 2025. PMID: 40330483 Free PMC article.
Robust cross-cohort gut microbiome associations with COVID-19 severity.
Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, Horgan M, O'Mahony L, O'Toole PW. Li J, et al. Among authors: sadlier c. Gut Microbes. 2023 Jan-Dec;15(1):2242615. doi: 10.1080/19490976.2023.2242615. Gut Microbes. 2023. PMID: 37550964 Free PMC article.
Healthcare globalization and medical tourism.
Sadlier C, Bergin C, Merry C. Sadlier C, et al. Clin Infect Dis. 2014 Jun;58(11):1642-3. doi: 10.1093/cid/ciu143. Epub 2014 Mar 11. Clin Infect Dis. 2014. PMID: 24619037 No abstract available.
62 results